FBTTX

About FBTTX

Fidelity Advisor Biotechnology Fund - Class M is a mutual fund specializing in the biotechnology sector. Its primary objective is capital appreciation by investing at least 80% of its assets in companies that are primarily engaged in the research, development, manufacture, and distribution of biotechnology products, services, and processes, or those significantly benefiting from advances in biotechnology. The fund offers exposure to a range of both established and innovative biotech firms, with significant holdings in leading healthcare companies such as AbbVie, Gilead Sciences, and Amgen. With portfolio assets exceeding $1.3 billion, the fund is positioned as a focused vehicle for investors seeking diversified access to the growth and innovation of the biotech industry. It is managed by Fidelity Investments, known for its research-driven approach and strong management team. The fund plays a key role in the market for those aiming to participate in the dynamic and rapidly evolving biotechnology sector, which is instrumental in driving advancements across healthcare and pharmaceuticals.